Raymond James & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Raymond James & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$325K	–	3950
2023 Q3	$325K	Buy	+500	New	+$266K	﹤0.01%	3161
2019 Q2	–	Sell	-2,500	Closed	-$365K	–	3750
2019 Q1	$365K	Hold	2,500	–	–	﹤0.01%	2869
2018 Q4	$246K	Hold	2,500	–	–	﹤0.01%	2985
2018 Q3	$293K	Hold	2,500	–	–	﹤0.01%	3046
2018 Q2	$204K	Hold	2,500	–	–	﹤0.01%	3253
2018 Q1	$206K	Buy	+2,500	New	+$525K	﹤0.01%	3119

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James & Associates's TMO Position: Q3 2024 in Review

Raymond James & Associates increased its Thermo Fisher Scientific (TMO) stake by 8.7% in Q3 2024, buying an estimated $27.7M and bringing the position to 586,785 shares worth $363M. The position accounts for 0.22% of the portfolio, ranked #81.

Raymond James & Associates first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Raymond James & Associates held 586,785 shares of Thermo Fisher Scientific worth $363M as of Q3 2024.
Raymond James & Associates bought 46,744 Thermo Fisher Scientific shares in Q3 2024, an estimated $27.7M.
Thermo Fisher Scientific made up 0.22% of Raymond James & Associates's portfolio in Q3 2024, its #81 holding.
Raymond James & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.